Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid

BACKGROUND: Bullous pemphigoid (BP) is an autoimmune blistering disorder that predominantly affects the elderly. As the main treatment for BP, systemic corticosteroids are often limited by their side effects. Safer treatment modalities are therefore needed. Dupilumab is a biologic agent used to trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yihua, Xu, Qiuyun, Chen, Lihong, Chen, Jiawen, Zhang, Jing, Zou, Ying, Gong, Ting, Ji, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552038/
https://www.ncbi.nlm.nih.gov/pubmed/34721404
http://dx.doi.org/10.3389/fimmu.2021.738907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552038/
https://www.ncbi.nlm.nih.gov/pubmed/34721404
http://dx.doi.org/10.3389/fimmu.2021.738907

Ejemplares similares